Our paper “Unexpected symptoms after rhTSH administration due to occult thyroid carcinoma metastasis”, recently was published.

Wolffenbuttel BHR, Coppes MH, Bongaerts AH, Glaudemans AW, Links TP.

Published in Neth J Med. 2013 Jun;71(5):253-6.

Abstract
18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) scintigraphy is a useful imaging technique in the evaluation of metastasised thyroid carcinoma. Administration of recombinant human thyrotropin (rhTSH, Thyrogen®) increases the diagnostic yield of this procedure. Here we present a 64-year-old male who was followed for Hürthle cell carcinoma of the thyroid with several intrapulmonary metastases. He developed sudden complaints of neck pain following rhTSH administration as part of the routine preparation for a diagnostic 18FDG-PET÷CT procedure..

Read the full article at http://www.njmonline.nl/getpdf.php?id=10000969